PTK2 and urinary bladder carcinoma: N-acetylgalactosaminyltransferase 1 (GALNT1) overexpression has been reported for the aberrant glycosylation of integrin α3β1 which leads to the change in the conformation of integrin and further induces focal adhesion kinase (FAK) activation in bladder cancer cells [35].